title: [Favourable response to the use of intravenous immunoglobulins in central pontine myelinolysis].
authors.forename: María Isabel
authors.initials: MI
authors.lastname: Parejo-Sánchez
authors.forename: Alfredo José
authors.initials: AJ
authors.lastname: Pardo-Cabello
authors.forename: María Victoria
authors.initials: MV
authors.lastname: Manzano-Gamero
authors.forename: Sonia
authors.initials: S
authors.lastname: de Luna-Sánchez
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications / Q000601:surgery; D059269:Chilaiditi Syndrome / Q000150:complications; D003937:Diagnosis, Differential; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications; D006973:Hypertension / Q000150:complications; D007008:Hypokalemia / Q000150:complications / Q000188:drug therapy; D007010:Hyponatremia / Q000150:complications / Q000188:drug therapy; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000150:complications / Q000601:surgery; D008297:Male; D008875:Middle Aged; D017590:Myelinolysis, Central Pontine / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D010437:Peptic Ulcer / Q000150:complications; D011013:Pneumonectomy; D011183:Postoperative Complications / Q000209:etiology / Q000628:therapy; D012074:Remission Induction; D020521:Stroke / Q000175:diagnosis; D014715:Vertebrobasilar Insufficiency / Q000150:complications
chemical_list: D016756:Immunoglobulins, Intravenous